The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder. ResMed makes continuous positive ...

The American Heart Association's school-based program awarded $605 to Lowell Elementary School for recess equipment.

Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19%Operating cash flow of $309 millionNote: A webcast of ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Thursday, January 30 based on AAII’s Stock Grades.

In 2023, the Global Drug Of Abuse Testing Market accounted for USD 6.8 Billion and is expected to reach around USD 11.8 Billion in 2032. Between 2023 and 2032, Lawrence John Prudour +91 91308 55334 ...